A triple agonist that targets the GLP-1, GIP, and glucagon receptors, designed to enhance weight loss and metabolic control.

In research trials, retatrutide has been shown to boost metabolism, suppress appetite, and improve insulin sensitivity. This triple action promotes greater fat burning and muscle preservation

Key Benefits

•Significant fat loss

•Appetite reduction

•Improved insulin sensitivity

•Increased metabolic rate

•Triple receptor activation

Science

•Agonist at GLP-1 / GIP / Glucagon receptors

•Enhances insulin secretion

•Increases energy expenditure

Dosing

•Weekly injections in clinical trials

Cycle Length

•12–48 weeks (research)

Vials Needed

•2–8 mg/week → 1–4 weeks per vial